ID23951A - Pengobatan diabetes dengan rosiglitazon dan insulin - Google Patents

Pengobatan diabetes dengan rosiglitazon dan insulin

Info

Publication number
ID23951A
ID23951A IDW991627A ID991627A ID23951A ID 23951 A ID23951 A ID 23951A ID W991627 A IDW991627 A ID W991627A ID 991627 A ID991627 A ID 991627A ID 23951 A ID23951 A ID 23951A
Authority
ID
Indonesia
Prior art keywords
rosiglitazone
insulin
diabetes
treatment
Prior art date
Application number
IDW991627A
Other languages
English (en)
Indonesian (id)
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID23951A publication Critical patent/ID23951A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IDW991627A 1997-06-18 1998-06-15 Pengobatan diabetes dengan rosiglitazon dan insulin ID23951A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9712866.4A GB9712866D0 (en) 1997-06-18 1997-06-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
ID23951A true ID23951A (id) 2000-06-08

Family

ID=10814527

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991627A ID23951A (id) 1997-06-18 1998-06-15 Pengobatan diabetes dengan rosiglitazon dan insulin

Country Status (30)

Country Link
EP (1) EP0999837A1 (h)
JP (1) JP2002504138A (h)
KR (1) KR20010013843A (h)
CN (1) CN1133431C (h)
AP (1) AP1287A (h)
AR (2) AR012997A1 (h)
AU (1) AU8216398A (h)
BG (1) BG104059A (h)
BR (1) BR9810444A (h)
CA (1) CA2294141A1 (h)
CO (1) CO4940454A1 (h)
DZ (1) DZ2521A1 (h)
EA (1) EA004800B1 (h)
GB (1) GB9712866D0 (h)
HU (1) HUP0003260A3 (h)
ID (1) ID23951A (h)
IL (1) IL133143A0 (h)
IN (1) IN189723B (h)
MA (1) MA26511A1 (h)
NO (1) NO996265D0 (h)
OA (1) OA11517A (h)
PE (1) PE104499A1 (h)
PL (1) PL343123A1 (h)
SK (1) SK179399A3 (h)
TR (1) TR199903095T2 (h)
TW (1) TW587937B (h)
UA (1) UA70299C2 (h)
UY (1) UY25050A1 (h)
WO (1) WO1998057636A1 (h)
ZA (1) ZA985237B (h)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) * 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
EA004534B1 (ru) 1999-04-23 2004-06-24 Смитклайн Бичам Плс Новый фармацевтический препарат
EP1133312B8 (en) * 1999-06-21 2007-10-17 Eli Lilly And Company Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
JP2003503356A (ja) 1999-06-25 2003-01-28 メドトロニック ミニメド インコーポレイテッド 多剤糖尿病治療
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
US6852694B2 (en) 2001-02-21 2005-02-08 Medtronic Minimed, Inc. Stabilized insulin formulations
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes
US20020198203A1 (en) * 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and a thiazolidinedione agent
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
PL210871B1 (pl) * 2002-11-08 2012-03-30 Hoffmann La Roche Pochodne oksazolu, sposób ich wytwarzania, środki farmaceutyczne i zastosowanie pochodnych oksazolu
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102389427A (zh) * 2011-10-10 2012-03-28 成都恒瑞制药有限公司 含有罗格列酮和盐酸西替利嗪的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ283339B6 (cs) * 1993-09-15 1998-03-18 Sankyo Company Limited Použití thiazolidinových derivátů pro výrobu léčivého přípravku pro léčení zhoršené tolerance glukosy pro zabránění nebo zpoždění nástupu diabetes mellitus nezávislé na inzulinu
EP0851757A2 (en) * 1995-08-10 1998-07-08 Warner-Lambert Company A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
ES2216062T3 (es) * 1995-09-18 2004-10-16 Ligand Pharmaceuticals, Inc. Tratamiento de la niddm con agonistas del rxr.

Also Published As

Publication number Publication date
AP1287A (en) 2004-06-26
NO996265L (no) 1999-12-17
ZA985237B (en) 2000-02-17
NO996265D0 (no) 1999-12-17
IL133143A0 (en) 2001-03-19
MA26511A1 (fr) 2004-12-20
KR20010013843A (ko) 2001-02-26
PL343123A1 (en) 2001-07-30
CN1260715A (zh) 2000-07-19
EP0999837A1 (en) 2000-05-17
EA200000042A1 (ru) 2000-08-28
DZ2521A1 (fr) 2003-02-08
HUP0003260A3 (en) 2001-12-28
CN1133431C (zh) 2004-01-07
AU8216398A (en) 1999-01-04
EA004800B1 (ru) 2004-08-26
UY25050A1 (es) 2000-09-29
AR012997A1 (es) 2000-11-22
WO1998057636A1 (en) 1998-12-23
BG104059A (en) 2000-10-31
BR9810444A (pt) 2000-09-05
AR015894A1 (es) 2001-05-30
HUP0003260A2 (hu) 2001-05-28
GB9712866D0 (en) 1997-08-20
UA70299C2 (en) 2004-10-15
OA11517A (en) 2004-02-04
TR199903095T2 (xx) 2000-08-21
PE104499A1 (es) 2000-01-13
CO4940454A1 (es) 2000-07-24
JP2002504138A (ja) 2002-02-05
TW587937B (en) 2004-05-21
IN189723B (h) 2003-04-19
AP9901718A0 (en) 1999-12-31
CA2294141A1 (en) 1998-12-23
SK179399A3 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
ID23372A (id) Pengobatan diabetes dengan tiazolidindion dan metformin
ID23951A (id) Pengobatan diabetes dengan rosiglitazon dan insulin
DE69720243D1 (de) Chemische modifikation von biomedizinischen materialien mit genipin
EE9900328A (et) Tiasooli benseensulfoonamiidid ß3-agonistidena diabeedi ja rasvumuse ravis
ID24211A (id) Pengobatan penyakit gula dengan thiazolidindion, insulin sekretatagogue dan diguanida
ID24065A (id) Pengobatan diabetes dengan tiozolidindinon dan sulfonilurea
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
NO20000229L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
IL133138A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
HK1028198A (en) Treatment of diabetes with rosiglitazone and insulin
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
HK1025263A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
BR9605424A (pt) Seringa auto-destrutiva e auto-bloqueante
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea